AAV9-mediated gene delivery of MCT1 to oligodendrocytes does not provide a therapeutic benefit in a mouse model of ALS.
Eykens C, Rossaert E, Duqué S, Rué L, Bento-Abreu A, Hersmus N, Lenaerts A, Kerstens A, Corthout N, Munck S, Van Damme P, Holt MG, von Jonquires G, Klugmann M, Van Den Bosch L, Robberecht W.
Eykens C, et al. Among authors: corthout n.
Mol Ther Methods Clin Dev. 2021 Jan 20;20:508-519. doi: 10.1016/j.omtm.2021.01.006. eCollection 2021 Mar 12.
Mol Ther Methods Clin Dev. 2021.
PMID: 33614825
Free PMC article.